Sign in
Stories
Assenagon Acquires AstraZeneca Stake
Share
ADR Surge and Drops in NY
ARCA Biopharma Revenue Insights
Alcon's 2024 AGM Agenda
Amgen's Weight-Loss Drugs Market Entranc...
Analyst Recommendations Impact Diverse C...
BayCom Corp's Q4 Earnings Optimism
Overview
API
Assenagon Asset Management S.A. has acquired a significant stake in AstraZeneca PLC, valued at approximately $2.24 million. The company's earnings growth and 'buy' rating have contributed to this investment. AstraZeneca, a leading pharmaceutical company, focuses on developing and commercializing prescription medicines in various therapeutic areas.
Ask a question
How do the identified better buys by top analysts compare to AstraZeneca's performance?
How might Assenagon Asset Management S.A.'s acquisition of AstraZeneca shares impact the pharmaceutical industry?
What factors contribute to AstraZeneca's 'buy' rating and earnings growth?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage
marke